These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23149638)

  • 1. Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy.
    González-Gay MA; González-Juanatey C; Miranda-Filloy JA; García-Unzueta MT; Llorca J
    Acta Reumatol Port; 2012; 37(2):155-9. PubMed ID: 23149638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
    Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.
    Sidiropoulos PI; Siakka P; Pagonidis K; Raptopoulou A; Kritikos H; Tsetis D; Boumpas DT
    Scand J Rheumatol; 2009; 38(1):6-10. PubMed ID: 18991190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.
    Del Porto F; Laganà B; Lai S; Nofroni I; Tinti F; Vitale M; Podestà E; Mitterhofer AP; D'Amelio R
    Rheumatology (Oxford); 2007 Jul; 46(7):1111-5. PubMed ID: 17449484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
    Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.
    Nowak B; Madej M; Łuczak A; Małecki R; Wiland P
    Adv Clin Exp Med; 2016; 25(1):43-50. PubMed ID: 26935497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.
    Hafström I; Rohani M; Deneberg S; Wörnert M; Jogestrand T; Frostegård J
    J Rheumatol; 2007 Sep; 34(9):1810-6. PubMed ID: 17696277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Garcia-Porrua C; Llorca J; Martin J
    Biomed Pharmacother; 2006 Dec; 60(10):673-7. PubMed ID: 17049201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis.
    Dessein PH; López-Mejias R; González-Juanatey C; Genre F; Miranda-Filloy JA; Llorca J; González-Gay MA
    J Rheumatol; 2014 Mar; 41(3):429-36. PubMed ID: 24488413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease.
    González-Juanatey C; Llorca J; González-Gay MA
    Arthritis Res Ther; 2011 Jun; 13(3):R101. PubMed ID: 21696620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis.
    Montes A; Corrales A; Calaza M; Lopez-Mejias R; Parra JA; González-Gay MA; González A
    Arthritis Rheumatol; 2015 Nov; 67(11):2861-5. PubMed ID: 26246227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
    Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
    Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
    Dessein PH; Joffe BI; Singh S
    Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis.
    Im CH; Kim NR; Kang JW; Kim JH; Kang JY; Bae GB; Nam EJ; Kang YM
    Rheumatology (Oxford); 2015 May; 54(5):808-15. PubMed ID: 25305139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis.
    Watanabe T; Takemura M; Sato M; Matsunami H; Seishima M; Shimizu K; Matsuoka T
    Int J Rheum Dis; 2014 Jan; 17(1):26-33. PubMed ID: 24472263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
    Savioli C; Ribeiro AC; Fabri GM; Calich AL; Carvalho J; Silva CA; Viana VS; Bonfá E; Siqueira JT
    J Clin Rheumatol; 2012 Jun; 18(4):180-4. PubMed ID: 22647860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.
    Chatterjee Adhikari M; Guin A; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2012 Apr; 41(5):669-75. PubMed ID: 22035626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.